Infinium Pharmachem Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 5/6
Infinium Pharmachem has a total shareholder equity of ₹602.3M and total debt of ₹112.4M, which brings its debt-to-equity ratio to 18.7%. Its total assets and total liabilities are ₹854.5M and ₹252.2M respectively. Infinium Pharmachem's EBIT is ₹159.2M making its interest coverage ratio 9.3. It has cash and short-term investments of ₹119.1M.
Anahtar bilgiler
18.7%
Borç/özkaynak oranı
₹112.44m
Borç
| Faiz karşılama oranı | 9.3x |
| Nakit | ₹119.11m |
| Eşitlik | ₹602.33m |
| Toplam yükümlülükler | ₹252.20m |
| Toplam varlıklar | ₹854.53m |
Son finansal sağlık güncellemeleri
Güncelleme yok
Recent updates
Investors Still Aren't Entirely Convinced By Infinium Pharmachem Limited's (NSE:INFINIUM) Earnings Despite 38% Price Jump
Sep 20
Many Still Looking Away From Infinium Pharmachem Limited (NSE:INFINIUM)
Aug 04Infinium Pharmachem (NSE:INFINIUM) Strong Profits May Be Masking Some Underlying Issues
Jun 12Infinium Pharmachem (NSE:INFINIUM) Strong Profits May Be Masking Some Underlying Issues
Nov 06Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: INFINIUM's short term assets (₹650.1M) exceed its short term liabilities (₹174.1M).
Uzun Vadeli Yükümlülükler: INFINIUM's short term assets (₹650.1M) exceed its long term liabilities (₹78.1M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: INFINIUM has more cash than its total debt.
Borcun Azaltılması: INFINIUM's debt to equity ratio has reduced from 151.4% to 18.7% over the past 5 years.
Borç Kapsamı: INFINIUM's operating cash flow is negative, therefore debt is not well covered.
Faiz Kapsamı: INFINIUM's interest payments on its debt are well covered by EBIT (9.3x coverage).